Europe Genital Warts Market – Industry Trends and Forecast to 2029

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical Europe Genital Warts Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Europe Genital Warts Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now

Europe Genital Warts Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
 2022 –2029
Diagram Market Size (Base Year)
 USD 1,519.14 Million
Diagram Market Size (Forecast Year)
 USD 2,552.19 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

Europe Genital Warts Market, By Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Europe Genital Warts Market

Europe Genital Warts Market Analysis and Size

The Europe genital warts market is expected to witness significant growth during the forecast period. Genital warts are caused because of the human papillomavirus (HPV). There are about 30-40 strains of HPV. As per the records of the World Health Organization (WHO) 2019, more than 1 million sexually transmitted infections (STIs) are acquired each day globally and more than 290 million women attain a human papillomavirus (HPV) infection. Recurrence of warts rises the demand for more advanced treatment. Several treatments are available for warts. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the Europe genital warts market in the forecast period 2022-2029. The expected CAGR of Europe genital warts market is tend to be around 6.70% in the mentioned forecast period. The market was valued at USD 1,519.14 million in 2021, and it would grow upto USD 2552.19 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Genital warts are one of the most recurrent kinds of sexually transmitted infections. HPV is the virus that is responsible for causing genital warts. People are likely to get infected with at least one type of human papillomavirus (HPV). Genital warts affect most moist tissues in the genital areas of male and female patients. Even though the genital infection is asymptomatic, it is frequently recognized as genital warts due to the onset of symptoms. It is projected that about 1% of sexually active men and women in the U.S. have genital warts.

Europe Genital Warts Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

Germany, France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe

Market Players Covered

Bausch Health Companies Inc (Canada), Merck & Co., Inc (U.S.), Taro Pharmaceutical Industries Ltd (Israel), CryoIQ (Sweden), GSK plc (U.K.), BioNTech SE (Germany), Serum Institute of India Pvt. Ltd (India), Fotona (U.S.), Orgenesis Inc (U.S.) and Perrigo Company plc (Ireland)

Market Opportunities
  • New Treatment Launches by Market Players
  • Increasing Demand for Retail Pharmacies
  • Increased Research and Development

Europe Genital Warts Market Dynamics

Drivers

  • Increased Cases of STI

The increasing prevalence of sexually transmitted infections (STIs) is expected to boost the market's growth. Around 38.4 million people were globally living with STI at the end of 2021. According to the WHO 2019, more than 1 million sexually transmitted infections (STIs) are acquired each day globally and more than 290 million women have a human papillomavirus (HPV) infection. Thus, these higher number of infections boost the market growth.

  • Rising Incidence of Cervical Cancer

The number of cervical cancer rates are high in many underdeveloped countries, where more than 80% of cervical cancer cases are diagnosed. According to the WHO, cervical cancer is the most common type of malignancy in women and the second leading cause of cancer-related death globally, responsible for over 300,000 fatalities per year. This boosts the market growth.

Opportunities

  • New Treatment Launches by Market Players

Market players are involved in launching new treatment platforms that are expected to increase the growth of the Europe genital warts market during the forecast period. For instance, in 2019, GenieMD, which is a global provider of telemedicine services, launched their telemedicine app iVisit that would allow the diagnosis and treatment of patients for genital warts through virtual visit with the physician.

  • Increasing Demand for Retail Pharmacies

The rise in cervical cancer led to the delivery of drugs through retail pharmacies, creating a surge in the number of retail pharmacies in highly developed countries. In addition, patients choose retail pharmacies to purchase drugs, as these are easily accessible.

  • Increased Research and Development

Growing R&D in order to develop treatment for genital warts is projected to increase the growth of the global genital warts market during the forecast period. For instance, University of Pretoria, South Africa, in collaboration with University of Stellenbosch, South Africa, are currently conducting clinical trials to study the effectiveness of human papillomavirus (HPV) vaccine against the existence of genital warts. The study was started in the year 2018 and is projected to be completed by 2023. At present, the study is in the Phase III clinical trial.

 Restraints/Challenges

  • Lack of Awareness

Even though the occurrence of genital warts is high among the population, but its diagnosis rate is still low. The low diagnostic rate of genital warts is because of the lack of awareness about the infection, which may impede the genital warts market growth. For instance, as per the Health Protection report in 2018, the diagnosis rate of genital warts in England among girls aged 15 to 17 decreased by 92% compared to 2014. Furthermore, existing treatment procedures are often painful or invasive and can have unfavorable outcomes such as scarring or dyspigmentation, often requiring frequent visits. This results in a reduction in the diagnostic rate, likely restraining the genital warts market.

  • High Cost

The huge expenditure associated with infection drugs, gels, or severe treatment procedures hamper market growth.

This Europe genital warts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe genital warts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Europe Genital Warts Market       

COVID-19 pandemic has benefited the global human papillomavirus infection drugs market positively. Even though there was lockdown and many of the tasks were in consideration with COVID-19, most healthcare workers are carrying out their tasks, and companies are spending greatly in vaccine development for HPV.

The bigger population demand for HPV vaccine is likely to boost the market during a pandemic. Vaccine manufacturers and other scientists are working continuously on the development of HPV vaccines as well as COVID viral symptoms, which is predicted to boost the market in the next years.

Europe Genital Warts Market Scope

The Europe genital warts market is segmented on the basis of morphology, prevention, cause, location, gender, dosage, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Morphology

  • Cauliflower-Like
  • Smooth Papular
  • Keratotic
  • Flat Warts

Prevention

  • Prevention
  • Diagnostics
  • Treatment

Cause

  • HPV 6
  • HPV 11
  • Others

Location

  • Vulva
  • Cervix Uteri
  • Urethra
  • Anus
  • Scrotum

Gender

  • Male
  • Female

Dosage

  • Cream
  • Gel
  • Ointment
  • Intramuscularly
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Europe Genital Warts Market Regional Analysis/Insights

The Europe genital warts market is analyzed and market size insights and trends are provided by morphology, prevention, cause, location, gender, dosage, distribution channel and end-user as referenced above.

The major countries covered in the Europe genital warts market report are Germany, France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe.

Germany is expected to dominate the market due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Genital Warts Market Share Analysis

The Europe genital warts market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe genital warts market.

Key players operating in the Europe genital warts market include:

  • Bausch Health Companies Inc (Canada)
  • Merck & Co., Inc (U.S.)
  • Taro Pharmaceutical Industries Ltd (Israel)
  • CryoIQ (Sweden)
  • GSK plc (U.K.)
  • BioNTech SE (Germany)
  • Serum Institute of India Pvt. Ltd (India)
  • Fotona (U.S.)
  • Orgenesis Inc (U.S.)
  • Perrigo Company plc (Ireland)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF THE EUROPE GENITAL WARTS MARKET
    4. CURRENCY AND PRICING
    5. LIMITATIONS
    6. MARKETS COVERED
  2. Europe GENITAL WARTS market: SEGMENTATION
    1. MARKETS COVERED
    2. GEOGRAPHICAL SCOPE
    3. YEARS CONSIDERED FOR THE STUDY
    4. DBMR TRIPOD DATA VALIDATION MODEL
    5. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
    6. MULTIVARIATE MODELLING
    7. DISTRIBUTION CHANNEL LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. VENDOR SHARE ANALYSIS
    10. MARKET END USER COVERAGE GRID
    11. SECONDARY SOURCES
    12. ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. Porter's Five Forces Model
  6. PESTEL Analysis
  7. Pipeline analysis: Europe genital warts market
  8. Europe GENITAL WARTS market: regulations
    1. CANADA
    2. U.S.
    3. EUROPE
    4. JAPAN
    5. MALAYSIA
    6. VIETNAM
    7. SOUTH AMERICA
  9. Market Overview
    1. drivers
      1. RISE IN PREVALENCE OF SEXUALLY TRANSMITTED DISEASES AND HUMAN PAPILLOMAVIRUS (HPV) VIRUS
      2. RISE OF MALE POPULATION
      3. RISE IN GOVERNMENT INITIATIVES AND AWARENESS PROGRAMMES
      4. RISE IN CLINICAL TRIALS
      5. RISE IN HEALTHCARE EXPENDITURE
    2. RESTRAINTS
      1. RISE IN COST FOR GENITAL WARTS TREATMENT
      2. SIDE EFFECTS OBSERVED WHILE UNDERGOING THE TREATMENT FOR GENITAL WARTS
      3. LACK OF PATIENT AND CONSUMER AWARENESS
      4. LESS DIAGNOSTIC RATE
    3. opportunities
      1. USE OF LASER TREATMENT AND CRYOTHERAPY FOR TREATMENT OF GENITAL WARTS.
      2. STRATEGIC INITIATIVES BY MARKET PLAYERS.
      3. RESEARCH AND DEVELOPMENT FOR GENERIC MEDICATIONS
    4. CHALLENGES
      1. RISE IN PRODUCT RECALL.
      2. PATIENT COMPLIANCE REGARDING THE USE OF VACCINES AND OINTMENTS FOR TREATMENT OF GENITAL WARTS
  10. IMPACT OF COVID-19 ON EUROPE GENITAL WARTS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS BY MANUFACTURERS
    5. CONCLUSION
  11. Europe GENITAL WARTS MARKET, BY MORPHOLOGY
    1. overview
    2. Cauliflower-Like
    3. Smooth Papular
    4. Keratotic
    5. Flat Warts
  12. Europe GENITAL WARTS MARKET, BY type
    1. overview
    2. prevention
    3. diagnostic
      1. hpv test
      2. pap test
    4. treatment
      1. Pharmacological Treatment
        1. Imiquimod
        2. Podophyllin and Podofilox
        3. Trichloroacetic Acid
        4. Sinecatechins
        5. others
      2. non- Pharmacological Treatment
        1. Cryotherapy
        2. Electrocautery
        3. Laser Treatment
        4. Surgical Excision
      3. Gardasil
      4. cervarix
  13. Europe GENITAL WARTS MARKET, BY cause
    1. overview
    2. HPV 6
    3. HPV 11
    4. Others
  14. Europe GENITAL WARTS MARKET, BY Location
    1. overview
    2. Vulva
    3. Cervix Uteri
    4. Urethra
    5. anus
    6. Scrotum
  15. Europe GENITAL WARTS MARKET, BY gender
    1. overview
    2. female
    3. male
  16. Europe GENITAL WARTS MARKET, BY dosage
    1. overview
    2. cream
    3. gel
    4. ointment
    5. Intramuscularly
    6. others
  17. Europe GENITAL WARTS MARKET, BY end user
    1. overview
    2. Hospitals
    3. Diagnostic Centers
    4. Surgical Centers
    5. Ambulatory Surgical Centers
    6. others
  18. Europe GENITAL WARTS MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Pharmacy Stores
    4. others
  19. EUROPE Genital warts market, by region
    1. europe
      1. GERMANY
      2. FRance
      3. U.K.
      4. italy
      5. spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Turkey
      10. Austria
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF Europe
  20. Europe Genital Warts Market: COMPANY landscape
    1. company share analysis: Europe
  21. Swot analysis
  22. company profile
    1. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. GlaxoSmithKline plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. bausch health companies inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. product portfolio
      5. RECENT DEVELOPMENTS
    4. ANI PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. BioNTech SE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. product portfolio
      5. RECENT DEVELOPMENTS
    6. cassiopea, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. cryoconcepts lp
      1. COMPANY SNAPSHOT
      2. product portfolio
      3. RECENT DEVELOPMENT
    8. CRYOIQ
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. CryoSurgery, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. edge pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FOTONA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. glenmark pharmaceutical inc., usa (a subsidiary of glenmark Pharmaceuticals Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. novan, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. ORGENESIS INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. PERRIGO COMPANY PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. serum institute of india pvt. ltd.
      1. COMPANY SNAPSHOT
      2. product portfolio
      3. RECENT DEVELOPMENT
    17. Taro Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    18. verrica pharmaceuticals
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. product portfolio
      4. RECENT DEVELOPMENTS
  23. questionnaire
  24. related reports

List of Table

TABLE 1 Europe genital warts Market, pipeline analysis

TABLE 2 Europe GENITAL WARTS Market, By morphology, 2019-2028 (USD MILLION)

TABLE 3 Europe CAULIFLOWER-LIKE in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 4 Europe smooth papular in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 5 Europe keratotic in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 6 Europe Flat Warts in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 7 Europe GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 8 Europe prevention In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 9 Europe diagnostic in GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 10 Europe diagnostic In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 11 Europe treatment in GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 12 Europe treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 13 Europe pharmacological treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 14 Europe non- pharmacological treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 15 Europe TREATMENT In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 16 Europe GENITAL WARTS Market, By cause, 2019-2028 (USD MILLION)

TABLE 17 Europe HPV 6 In GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 18 Europe HPV 11 In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 19 Europe others In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 20 Europe GENITAL WARTS MARKET, By Location, 2019-2028 (USD MILLION)

TABLE 21 Europe vulva In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 22 Europe Cervix Uteri In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 23 Europe urethra In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 24 Europe ANUS In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 25 Europe Scrotum In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 26 Europe GENITAL WARTS MARKET, By gender, 2019-2028 (USD MILLION)

TABLE 27 Europe female In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 28 Europe male In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 29 Europe GENITAL WARTS MARKET, By Dosage, 2019-2028 (USD MILLION)

TABLE 30 Europe cream In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 31 Europe gel In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 32 Europe ointment In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 33 Europe intramuscularly In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 34 Europe others In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 35 Europe GENITAL WARTS MARKET, By end user, 2019-2028 (USD MILLION)

TABLE 36 Europe HOSPITALS in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 37 Europe diagnostic centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 38 Europe surgical centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 39 Europe ambulatory surgical centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 40 Europe others in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 41 Europe GENITAL WARTS MARKET, By distribution channel 2019-2028 (USD MILLION)

TABLE 42 Europe direct tender in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 43 Europe pharmacy stores in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 44 Europe others in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 45 europe GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 46 Europe GENITAL WARTS MARKET, By MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 47 Europe GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 Europe Diagnostic in GENITAL WARTS MARKET, by TYPE, 2019-2028 (USD MILLION)

TABLE 49 Europe Treatment in GENITAL WARTS MARKET, By Type, 2019-2028 (USD MILLION)

TABLE 50 Europe PHARMACOLOGICAL TREATMENT in GENITAL WARTs Market, By Type, 2019-2028 (USD MILLION)

TABLE 51 Europe prevention GENITAL WARTs Market, By TREATMENT, 2019-2028 (USD MILLION)

TABLE 52 europe GARDASIL GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 53 europe CERVARIX GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 54 Europe Non-Pharmacological Treatment in GENITAL WARTs Market, By Type, 2019-2028 (USD MILLION)

TABLE 55 Europe GENITAL WARTs Market, BY CAUSe, 2019-2028 (USD MILLION)

TABLE 56 Europe GENITAL WARTs Market, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 57 Europe GENITAL WARTs Market, BY gender, 2019-2028 (USD MILLION)

TABLE 58 Europe GENITAL WARTs Market, BY Dosage, 2019-2028 (USD MILLION)

TABLE 59 Europe GENITAL WARTs Market, BY end user, 2019-2028 (USD MILLION)

TABLE 60 Europe GENITAL WARTs Market, BY Distribution Channel, 2019-2028 (USD MILLION)

TABLE 61 Germany genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 62 Germany genital warts Market, By type, 2019-2028 (USD MILLION)

TABLE 63 Germany Diagnostic in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 64 Germany Treatment in genital warts MARKET, BY Type, 2019-2028 (USD MILLION)

TABLE 65 Germany Pharmacological Treatment in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 66 Germany genital warts market, by TREATMENT, 2019-2028 (USD MILLION)

TABLE 67 Germany Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 68 Germany genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 69 Germany genital warts market, by location, 2019-2028 (USD MILLION)

TABLE 70 Germany genital warts MARKET, BY gender, 2019-2028 (USD MILLION)

TABLE 71 Germany genital warts MARKET, BY Dosage, 2019-2028 (USD MILLION)

TABLE 72 Germany genital warts MARKET, BY end user, 2019-2028 (USD MILLION)

TABLE 73 Germany genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 74 France genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 75 France genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 76 France Diagnostic IN genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 77 France Treatment IN genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 78 France Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 79 France genital warts market, by Treatment, 2019-2028 (USD MILLION)

TABLE 80 France treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 81 France genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 82 France genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 83 France genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 84 France genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 85 France genital warts market, by end user, 2019-2028 (USD MILLION)

TABLE 86 France genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 87 u.K. genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 88 u.K. genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 89 u.K. Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 90 u.K. Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 91 u.K. pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 92 u.K. genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 93 u.K. Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 94 u.K. genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 95 u.K. genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 96 u.K. genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 97 u.K. genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 98 u.K. genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 99 u.K. genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 100 ITALY GENITAL warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 101 ITALY GENITAL warts Market, By type, 2019-2028, (USD Million)

TABLE 102 ITALY GENITAL warts Market, By Diagnostics type, 2019-2028, (USD Million)

TABLE 103 ITALY treatment in GENITAL warts Market, By type, 2019-2028, (USD Million)

TABLE 104 ITALY Pharmacological in GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 105 ITALY GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 106 ITALY Non-Pharmacological Treatment in GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 107 ITALY GENITAL warts Market, By cause, 2019-2028, (USD Million)

TABLE 108 ITALY GENITAL warts Market, By Location, 2019-2028, (USD Million)

TABLE 109 ITALY GENITAL warts Market, By gender, 2019-2028, (USD Million)

TABLE 110 ITALY GENITAL warts Market, By Dosage, 2019-2028, (USD Million)

TABLE 111 ITALY GENITAL warts Market, By END USER, 2019-2028, (USD Million)

TABLE 112 ITALY GENITAL warts Market, By Distribution Channel, 2019-2028, (USD Million)

TABLE 113 Spain Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 114 Spain genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 115 Spain Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 116 Spain Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 117 Spain pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 118 Spain genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 119 Spain Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 120 Spain genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 121 Spain genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 122 Spain genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 123 Spain genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 124 Spain genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 125 Spain genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 126 Netherlands genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 127 Netherlands genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 128 Netherlands Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 129 Netherlands Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 130 Netherlands pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 131 Netherlands genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 132 Netherlands Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 133 Netherlands genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 134 Netherlands genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 135 Netherlands genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 136 Netherlands genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 137 Netherlands genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 138 Netherlands genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 139 Russia genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 140 Russia genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 141 Russia Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 142 Russia Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 143 Russia pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 144 Russia genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 145 Russia Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 146 Russia genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 147 Russia genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 148 Russia genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 149 Russia genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 150 Russia genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 151 Russia genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 152 Switzerland Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 153 Switzerland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 154 Switzerland Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 155 Switzerland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 156 Switzerland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 157 Switzerland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 158 Switzerland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 159 Switzerland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 160 Switzerland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 161 Switzerland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 162 Switzerland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 163 Switzerland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 164 Switzerland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 165 TURKEY GENITAL warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 166 TURKEY GENITAL warts Market, By type, 2019-2028 (USD MILLION)

TABLE 167 TURKEY Diagnostic in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 168 TURKEY Treatment in genital warts MARKET, BY Type, 2019-2028 (USD MILLION)

TABLE 169 TURKEY Pharmacological Treatment in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 170 TURKEY Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 171 TURKEY genital warts market, by TREATMENT, 2019-2028 (USD MILLION)

TABLE 172 TURKEY GENITAL warts market, by cause, 2019-2028 (USD MILLION)

TABLE 173 TURKEY GENITAL warts market, by location, 2019-2028 (USD MILLION)

TABLE 174 TURKEY GENITAL warts MARKET, BY gender, 2019-2028 (USD MILLION)

TABLE 175 TURKEY GENITAL warts MARKET, BY Dosage, 2019-2028 (USD MILLION)

TABLE 176 TURKEY GENITAL warts MARKET, BY end user, 2019-2028 (USD MILLION)

TABLE 177 TURKEY GENITAL warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 178 Austria genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 179 Austria genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 180 AUSTRIA Diagnostic IN genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 181 AUSTRIA Treatment IN genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 182 AUSTRIA Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 183 AUSTRIA genital warts market, by Treatment, 2019-2028 (USD MILLION)

TABLE 184 AUSTRIA treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 185 AUSTRIA genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 186 AUSTRIA genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 187 AUSTRIA genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 188 AUSTRIA genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 189 AUSTRIA genital warts market, by end user, 2019-2028 (USD MILLION)

TABLE 190 AUSTRIA genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 191 Norway genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 192 Norway genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 193 Norway Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 194 Norway Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 195 Norway pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 196 Norway genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 197 Norway Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 198 Norway genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 199 Norway genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 200 Norway genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 201 Norway genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 202 Norway genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 203 Norway genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 204 Hungary genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 205 Hungary genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 206 Hungary Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 207 Hungary Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 208 Hungary pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 209 Hungary genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 210 Hungary Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 211 Hungary genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 212 Hungary genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 213 Hungary genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 214 Hungary genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 215 Hungary genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 216 Hungary genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 217 Lithuania genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 218 Lithuania genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 219 Lithuania Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 220 Lithuania Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 221 Lithuania pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 222 Lithuania genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 223 Lithuania Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 224 Lithuania genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 225 Lithuania genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 226 Lithuania genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 227 Lithuania genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 228 Lithuania genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 229 Lithuania genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 230 Ireland genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 231 Ireland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 232 Ireland Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 233 Ireland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 234 Ireland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 235 Ireland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 236 Ireland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 237 Ireland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 238 Ireland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 239 Ireland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 240 Ireland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 241 Ireland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 242 Ireland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 243 Poland genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 244 Poland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 245 Poland Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 246 Poland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 247 Poland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 248 Poland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 249 Poland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 250 Poland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 251 Poland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 252 Poland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 253 Poland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 254 Poland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 255 Poland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 256 REST OF europe Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 Europe genital warts market: segmentation

FIGURE 2 Europe genital warts MARKET: data triangulation

FIGURE 3 EUROPE genital warts MARKET: DROC ANALYSIS

FIGURE 4 Europe genital warts MARKET: Europe VS REGIONAL ANALYSIS

FIGURE 5 Europe genital warts MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe genital warts MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe genital warts MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE GENITAL WARTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 Europe genital warts MARKET: MARKET end user COVERAGE GRID

FIGURE 10 EUROPE genital warts MARKET: SEGMENTATION

FIGURE 11 RISE OF MALE POPULATION is expected to drive the Europe genital warts MARKET in the forecast period of 2021 to 2028

FIGURE 12 cauliflower-like segment is expected to account for the largest share of the Europe genital warts market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTs, OPPORTUNITIES AND CHALLENGES OF EUROPE genital warts MARKET

FIGURE 14 PREVALENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S., AUSTRALIA AND CANADA

FIGURE 15 INFECTION RATE OF SEXUALLY TRANSMITTED DISEASES (STDS) IN THE FOLLOWING COUNTRIES

FIGURE 16 Europe GENITAL WARTS MARKET: BY morphology, 2020

FIGURE 17 Europe GENITAL WARTS MARKET: BY morphology, 2021-2028 (USD MILLION)

FIGURE 18 Europe GENITAL WARTS MARKET: BY morphology, CAGR (2021-2028)

FIGURE 19 Europe GENITAL WARTS MARKET: BY morphology, LIFELINE CURVE

FIGURE 20 Europe GENITAL WARTS MARKET: BY type, 2020

FIGURE 21 Europe GENITAL WARTS MARKET: BY type, 2021-2028 (USD MILLION)

FIGURE 22 Europe GENITAL WARTS MARKET: BY type, CAGR (2021-2028)

FIGURE 23 Europe GENITAL WARTS MARKET: BY type, LIFELINE CURVE

FIGURE 24 Europe GENITAL WARTS market: BY cause, 2020

FIGURE 25 Europe GENITAL WARTS market: BY cause, 2021-2028 (USD MILLION)

FIGURE 26 Europe GENITAL WARTS market: BY cause, CAGR (2021-2028)

FIGURE 27 Europe GENITAL WARTS market: BY cause, LIFELINE CURVE

FIGURE 28 Europe GENITAL WARTS MARKET: BY Location 2020

FIGURE 29 Europe GENITAL WARTS MARKET: BY Location 2021-2028 (USD MILLION)

FIGURE 30 Europe GENITAL WARTS MARKET: BY Location CAGR (2021-2028)

FIGURE 31 Europe GENITAL WARTS MARKET: BY Location, LIFELINE CURVE

FIGURE 32 Europe GENITAL WARTS MARKET: BY Gender 2020

FIGURE 33 Europe GENITAL WARTS MARKET: BY Gender 2021-2028 (USD MILLION)

FIGURE 34 Europe GENITAL WARTS MARKET: BY Gender CAGR (2021-2028)

FIGURE 35 Europe GENITAL WARTS MARKET: BY Gender, LIFELINE CURVE

FIGURE 36 Europe GENITAL WARTS MARKET: BY Dosage 2020

FIGURE 37 Europe GENITAL WARTS MARKET: BY Dosage 2021-2028 (USD MILLION)

FIGURE 38 Europe GENITAL WARTS MARKET: BY Dosage CAGR (2021-2028)

FIGURE 39 Europe GENITAL WARTS MARKET: BY Dosage, LIFELINE CURVE

FIGURE 40 Europe GENITAL WARTS MARKET: BY END USER, 2020

FIGURE 41 Europe GENITAL WARTS MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 42 Europe GENITAL WARTS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 43 Europe GENITAL WARTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 Europe GENITAL WARTS MARKET: BY distribution channel, 2020

FIGURE 45 Europe GENITAL WARTS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 46 Europe GENITAL WARTS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 47 Europe GENITAL WARTS MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 48 Europe EUROPE GENITAL WARTS MARKET: SNAPSHOT (2020)

FIGURE 49 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2020)

FIGURE 50 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 52 Europe EUROPE GENITAL WARTS MARKET: BY MORPHOLOGY (2021-2028)

FIGURE 53 Europe Genital Warts Market: company share 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe genital warts market size will be worth USD 2552.19 million by 2029.
The growth rate of the Europe genital warts market is 6.70%.
The increasing prevalence of sexually transmitted infections & rising incidence of cervical cancer are the growth drivers of the Europe genital warts market.
Morphology, prevention, cause, location, gender, dosage, distribution channel and end-user are the factors on which the Europe genital warts market research is based.
Major companies in the Europe genital warts market are Bausch Health Companies Inc (Canada), Merck & Co., Inc (U.S.), Taro Pharmaceutical Industries Ltd (Israel), CryoIQ (Sweden), GSK plc (U.K.), BioNTech SE (Germany), Serum Institute of India Pvt. Ltd (India), Fotona (U.S.), Orgenesis Inc (U.S.) and Perrigo Company plc (Ireland).

Browse Related Pages

Banner